RVP: Retractable Tech Company Assets

Corporate emblem and logo of Retractable Technologies (RVP)

Retractable Technologies (RVP) generates revenue through the sale of VanishPoint safety blood collection systems and syringes designed to eliminate physician needlestick injuries. Production efficiency is sustained by the implementation of energy-saving molding technologies and wastewater treatment. This price chart reflects the dynamics of total assets, which currently stand at 154.51. This strategy minimizes toxic waste volume, simplifying polymer disposal and supporting ESG principles.

Retractable Technologies (RVP) Company Total Assets: for the period 07/04/2022 - 10/27/2026

Financial and market metric breakdowns for retractable.com (RVP)

- price and consensus price forecast:
Stock Quotes Retractable Technologies, Inc.|RVP - Analyst Consensus Forecast
- market capitalization data:
Market Value Retractable Technologies, Inc.|RVP - Enterprise Value
- book capitalization data:
Equity per Share Retractable Technologies|RVP - Book Capitalization|Market Capitalization to Book Value retractable.com|RVP - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio Retractable Technologies|RVP - Long-Term Debt to Capital|Short-Term Debt to Capital Retractable Technologies, Inc.|RVP - Company Debts|Debt to Book Capitalization Ratio Retractable Technologies, Inc.
Basic company analysis:RVP, Retractable Tech
Manufactured product of retractable.com

Total assets, calculated inversely via ROA, combine equity and liabilities to assess the business's resource potential. The current value of 154.51 in the total asset analysis (via ROA) reflects the management efficiency of production capacities and the engineering staff at Retractable Technologies (RVP), demonstrating a balance between investments in medical device safety and the company's final profitability.

Competitors of Retractable Technologies (RVP)

intuitive.com (ISRG) - Cumulative Company Assets|Company Total Assets DHR (Danaher)|Company Assets BD|Company Total Assets STERIS Corporation STE|Total Business Assets West Pharma Corp (WST)|Company Total Assets BAX|Company Total Asset Base masimo.com MASI|STVN: Company Total Assets|TFX - Cumulative Company Assets|MMSI: Company Total Assets|NVST (Nobel Biocare) - Company Total Assets|Aggregate Company Assets ICU Medical, Inc.|Aggregate Company Assets dentsplysirona.com (XRAY)|LeMaitre Vascular (LMAT) - Cumulative Company Assets|Aggregate Asset Value AtriCure Inc (ATRC)|Company Total Assets STAA|ChromaDex - Company Total Asset Base|ZimVie Inc. (ZIMV) - Aggregate Company Assets|ANGO: Total Business Assets|Cerus - Aggregate Company Assets|Company Total Asset Base Alpha Teknova|Monogram Technologies Inc (MGRM) - Cumulative Company Assets|Aggregate Business Assets STSS|InfuSystem Holdings (INFU) - Aggregate Company Assets|Aggregate Asset Value utahmed.com UTMD|Cumulative Company Assets KRMD (KORU Medical)|Nyxoah SA - Company Total Assets|MBOT: Aggregate Company Assets|PDEX - Cumulative Company Assets|Company Total Assets ZTEK|ELUT (elutia.com) - Company Assets|Aggregate Company Assets Milestone Scientific Inc. (MLSS)|Total Business Assets NEXGEL Inc. (NXGL)|Cumulative Company Assets Harvard Bioscience|Aggregate Business Assets FEMY (Femasys Corporation)|Aggregate Company Assets MHUA|Predictive Oncology Inc - Company Total Asset Base|Aggregate Company Assets Callan JMB Corp (CJMB)|ATRI - Aggregate Asset Value|Company Total Assets NURO